Necrotizing soft tissue infections: are we making any progress?

M A Malangoni1

  • 1Department of Surgery, Case Western Reserve University School of Medicine, MetroHealth Medical Center Campus, Cleveland, Ohio 44109, USA. mmalangoni@metrohealth.org

Surgical Infections
|February 22, 2003
PubMed
Abstract

Insights

Early recognition and treatment of necrotizing soft tissue infections (NSTIs) are crucial for reducing mortality. Prompt surgical debridement, antibiotics, and supportive care improve outcomes for these severe bacterial infections.

Area of Science:

  • Infectious Diseases
  • Surgical Critical Care
  • Microbiology

Background:

  • Necrotizing soft tissue infections (NSTIs) are severe conditions with high mortality rates.
  • Diagnosis of NSTIs can be challenging due to diverse bacterial involvement.

Purpose of the Study:

  • To review the diagnosis and therapeutic strategies for necrotizing soft tissue infections.
  • To identify factors influencing outcomes in patients with NSTIs.

Main Methods:

  • Literature review focusing on diagnosis and therapy of NSTIs.
  • Analysis of factors associated with mortality and adverse outcomes.

Main Results:

  • Advanced age, organ failure, lactic acidemia, infection extent, and delayed surgery correlate with adverse outcomes.
  • Early mortality is often due to septic shock, while late mortality results from multiple organ failure.

Conclusions:

  • Early identification and intervention are key to reducing NSTI mortality.
  • Effective treatment includes prompt surgical debridement, broad-spectrum antibiotics, and comprehensive physiologic support.

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
Cellular Injury IV: Necrosis01:16

Cellular Injury IV: Necrosis

Necrosis is a form of irreversible cell death caused by severe injury such as ischemia, toxins, or trauma. Unlike programmed cell death, it is an uncontrolled, pathological process that typically provokes inflammation in surrounding tissues.Pathophysiologic ChangesNecrosis begins when cells sustain critical damage, leading to swelling of organelles, particularly mitochondria, and rapid ATP depletion. As energy levels decline, membrane ion pumps fail, leading to calcium influx and eventually,...